Costanzo Michael J, Yabut Stephen C, Zhang Han-Cheng, White Kimberley B, de Garavilla Lawrence, Wang Yuanping, Minor Lisa K, Tounge Brett A, Barnakov Alexander N, Lewandowski Frank, Milligan Cynthia, Spurlino John C, Abraham William M, Boswell-Smith Victoria, Page Clive P, Maryanoff Bruce E
Research and Early Development, Johnson & Johnson Pharmaceutical Research & Development, Welsh & McKean Roads, Spring House, PA 19477-0776, USA.
Bioorg Med Chem Lett. 2008 Mar 15;18(6):2114-21. doi: 10.1016/j.bmcl.2008.01.093. Epub 2008 Jan 30.
We have explored a series of spirocyclic piperidine amide derivatives (5) as tryptase inhibitors. Thus, 4 (JNJ-27390467) was identified as a potent, selective tryptase inhibitor with oral efficacy in two animal models of airway inflammation (sheep and guinea pig asthma models). An X-ray co-crystal structure of 4 x tryptase revealed a hydrophobic pocket in the enzyme's active site, which is induced by the phenylethynyl group and is comprised of amino acid residues from two different monomers of the tetrameric protein.
我们已经研究了一系列螺环哌啶酰胺衍生物(5)作为类胰蛋白酶抑制剂。因此,4(JNJ - 27390467)被鉴定为一种强效、选择性类胰蛋白酶抑制剂,在两种气道炎症动物模型(绵羊和豚鼠哮喘模型)中具有口服疗效。4与类胰蛋白酶的X射线共晶体结构显示,该酶活性位点存在一个疏水口袋,它由苯乙炔基诱导形成,且由四聚体蛋白两个不同单体的氨基酸残基组成。